Brolucizumab-dbll ka pahu kui

Anter

• Ma mua o ka loaʻa ʻana o ka injection brolucizumab-dbll,
• ʻO kekahi mau hopena ʻē aʻe mai ka injection brolucizumab-dbll hiki ke koʻikoʻi. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli, e kāhea koke i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.

Hoʻohana ʻia ka injection Brolucizumab-dbll e mālama i ka hoʻohaʻahaʻa macular e pili ana i ka makahiki (AMD; kahi maʻi mau o ka maka i kumu e nalowale ai ka hiki ke ʻike pololei i mua a e ʻoi aku ka paʻakikī o ka heluhelu, hoʻokele, a hana i nā hana o kēlā me kēia lā) . Aia ʻo Brolucizumab-dbll i loko o ka papa o nā lāʻau i kapa ʻia he vagon endothelial factor factor A (VEGF-A) antagonists. Hana ia ma ka hoʻōki ʻana i ka ulu ʻana o ke kīʻaha koko a me nā leakage i nā maka (s) i kumu e nalowale ka hihi.

Hele mai ʻo Brolucizumab-dbll ma ke ʻano he hopena (wai) e hoʻokomo ʻia i ka maka e ke kauka. Hāʻawi pinepine ʻia ia i ke keʻena o ke kauka i hoʻokahi manawa i kēlā me kēia 25 a 31 mau lā no nā mahele he 3, a laila hoʻokahi i kēlā me kēia 8 a 12 mau pule.

Ma mua o ka loaʻa ʻana o kahi injection brolucizumab-dbll, e hoʻomaʻemaʻe kāu kauka i kou maka e pale ai i ka maʻi a palu i kou maka e hoʻoliʻiliʻi i ka hōʻoluʻolu i ka wā o ka injection. ʻIke paha ʻoe i ke kaomi o kou maka ke kiki ʻia ka lāʻau. Ma hope o kāu hoʻopili ʻana, pono kāu kauka e nānā i kou mau maka ma mua o kou haʻalele ʻana i ke keʻena.

Mālama ʻo Brolucizumab-dbll i ka AMD pulu, akā ʻaʻole ia e hoʻōla iā ia. E nānā pono kāu kauka iā ʻoe e ʻike i ka maikaʻi o ka hana a brolucizumab-dbll iā ʻoe. E kamaʻilio me kāu kauka e pili ana i ka lōʻihi e hoʻomau ai ʻoe i ka lāʻau me brolucizumab-dbll.

E noi i kāu kauka lāʻau a kauka paha no kahi kope o ka ʻike a ka mea hana no ka mea maʻi.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka loaʻa ʻana o ka injection brolucizumab-dbll,

• e haʻi i kāu kauka a me ka kauka inā he maʻi ʻoe i ka brolucizumab-dbll, i nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i ka brolucizumab-dbll injection. E noi i kāu kauka lāʻau no kahi papa inoa o nā mea hoʻohui.
• e haʻi i kāu kauka a me ka mea kauka lāʻau i nā lāʻau lapaʻau, nā wikamina, nā mea hoʻopihapiha, a me nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe.
• e haʻi i kāu kauka inā loaʻa ʻoe i kahi maʻi i loko a i ʻole ka maka o ka maka. E haʻi paha kāu kauka iā ʻoe ʻaʻole pono ʻoe e loaʻa i ka injection brolucizumab-dbll.
• e haʻi i kāu kauka inā loaʻa kāu olakino.
• e haʻi i kāu kauka inā hāpai ʻoe a i ʻole hoʻolālā e hāpai. ʻAʻole pono ʻoe e hāpai i ka wā o kāu mālama ʻana me ka injection brolucizumab-dbll a no 1 mahina ma hope o kāu hopena hope loa. Inā hāpai ʻoe i ka loaʻa ʻana o ka injection brolucizumab-dbll, e kāhea i kāu kauka.
• e haʻi i kāu kauka inā ʻoe e hānai umauma. Mai hānai umauma ʻoiai ʻoe e loaʻa ana i ka injection brolucizumab-dbll a no 1 mau mahina ma hope o kāu hopena hope loa.
• pono ʻoe e ʻike ʻo ka brolucizumab-dbll injection ke kumu o nā pilikia o ka hihi ma hope koke o kou loaʻa ʻana o ka ʻume. Mai hoʻokele i kahi kaʻa a hana i nā mīkini a hiki i ka hoʻi ʻana o kāu ʻike i ka maʻamau.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.

Inā ʻoe e nalo i kahi manawa e loaʻa ai ka injection brolucizumab-dbll, e kāhea koke i kāu kauka.

ʻO kekahi mau hopena ʻē aʻe mai ka injection brolucizumab-dbll hiki ke koʻikoʻi. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli, e kāhea koke i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.

• ʻeha o ka maka, ʻulaʻula, a i ʻole ke ʻike i ka malamalama
• nā hoʻololi i ka hihiʻo
• ke ʻike nei iā '' floaters '' a i ʻole nā ​​specks liʻiliʻi
• ke kahe ʻana o ka maka i loko a i ʻole
• pehu o ka maka a i ʻole ka lihilihi maka
• ʻehu, hives, ʻume, a ʻulaʻula paha

Hoʻokumu paha ʻo Brolucizumab-dbll i nā hopena ʻē aʻe. Kāhea i kāu kauka inā loaʻa iā ʻoe kekahi pilikia maʻamau i ka loaʻa ʻana o kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

Mālama i nā manawa āpau me kāu kauka.

E nīnau i kāu kauka lāʻau i nā nīnau āu e pili ana i ka injection brolucizumab-dbll.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

• ʻO Beovu^®